Rosner et al., 2021 - Google Patents
Human embryo models and drug discoveryRosner et al., 2021
View HTML- Document ID
- 6148737001236229329
- Author
- Rosner M
- Reithofer M
- Fink D
- Hengstschläger M
- Publication year
- Publication venue
- International journal of molecular sciences
External Links
Snippet
For obvious reasons, such as, eg, ethical concerns or sample accessibility, model systems are of highest importance to study the underlying molecular mechanisms of human maladies with the aim to develop innovative and effective therapeutic strategies. Since many years …
- 210000001161 Embryo, Mammalian 0 title abstract description 31
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICRO-ORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING OR MAINTAINING MICRO-ORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/06—Animal cells or tissues; Human cells or tissues ; Not used, see subgroups
- C12N5/0602—Vertebrate cells
- C12N5/0603—Embryonic cells ; Embryoid bodies
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICRO-ORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING OR MAINTAINING MICRO-ORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/06—Animal cells or tissues; Human cells or tissues ; Not used, see subgroups
- C12N5/0602—Vertebrate cells
- C12N5/067—Hepatocytes
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12M—APPARATUS FOR ENZYMOLOGY OR MICROBIOLOGY; APPARATUS FOR CULTURING MICROORGANISMS FOR PRODUCING BIOMASS, FOR GROWING CELLS OR FOR OBTAINING FERMENTATION OR METABOLIC PRODUCTS, i.e. BIOREACTORS OR FERMENTERS
- C12M23/00—Constructional details, e.g. recesses, hinges
- C12M23/02—Form or structure of the vessel
- C12M23/10—Petri dish
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
- G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12M—APPARATUS FOR ENZYMOLOGY OR MICROBIOLOGY; APPARATUS FOR CULTURING MICROORGANISMS FOR PRODUCING BIOMASS, FOR GROWING CELLS OR FOR OBTAINING FERMENTATION OR METABOLIC PRODUCTS, i.e. BIOREACTORS OR FERMENTERS
- C12M23/00—Constructional details, e.g. recesses, hinges
- C12M23/34—Internal compartments or partitions
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Azar et al. | The use of stem cell-derived organoids in disease modeling: an update | |
| Kondo et al. | Application of cancer organoid model for drug screening and personalized therapy | |
| Ho et al. | Disease modeling using 3D organoids derived from human induced pluripotent stem cells | |
| Rehakova et al. | Clinical-grade human pluripotent stem cells for cell therapy: characterization strategy | |
| Antoni et al. | Three-dimensional cell culture: a breakthrough in vivo | |
| Miranda et al. | Towards multi-organoid systems for drug screening applications | |
| Rosner et al. | Human embryo models and drug discovery | |
| Zahumenska et al. | Induced pluripotency: A powerful tool for in vitro modeling | |
| Chitturi Suryaprakash et al. | Three-dimensional cell culture models to investigate oral carcinogenesis: a scoping review | |
| Kühl et al. | Human lung organoids—a novel experimental and precision medicine approach | |
| Sahara | Recent advances in generation of in vitro cardiac organoids | |
| Maenhoudt et al. | Modeling endometrium biology and disease | |
| Piraino et al. | Salivary gland tissue engineering approaches: state of the art and future directions | |
| Li et al. | Human pluripotent stem cell-derived hepatocyte-like cells and organoids for liver disease and therapy | |
| Amato et al. | Cholangiocarcinoma disease modelling through patients derived organoids | |
| Denker | Autonomy in the development of stem cell-derived embryoids: sprouting blastocyst-like cysts, and ethical implications | |
| Antonucci et al. | Amniotic fluid stem cells: a novel source for modeling of human genetic diseases | |
| Lin et al. | Effects of substrate-coating materials on the wound-healing process | |
| Gómez-Álvarez et al. | Addressing key questions in organoid models: who, where, how, and why? | |
| Hisha et al. | Lingual epithelial stem cells and organoid culture of them | |
| Jabri et al. | Bioengineered organoids offer new possibilities for liver cancer studies: a review of key milestones and challenges | |
| Denker | Self-organization of stem cell colonies and of early mammalian embryos: recent experiments shed new light on the role of autonomy vs. external instructions in basic body plan development | |
| Munro et al. | Applications for colon organoid models in cancer research | |
| Werner et al. | Primary Lung Cancer Organoids for Personalized Medicine—Are They Ready for Clinical Use? | |
| Oh et al. | In vitro embryogenesis and gastrulation using stem cells in mice and humans |